Silvio Inderbitzin
Director/Board Member chez KINARUS THERAPEUTICS HOLDING AG
Profil
Silvio Inderbitzin is currently the Chief Executive Officer at Mavena International AG and the Chairman at Hänseler Holding AG.
He is also the Chairman at Hthc High Tech Home Care AG, the Chairman at Vital Solutions Swiss AG, and the Director at Ulrich Jüstrich Holding AG, among other current positions.
In the past, Dr. Inderbitzin served as the Independent Director at Spexis Ltd.
and the Chief Executive Director & Director at Spirig Pharma AG.
He also held positions as the Director at MEDUDEM AG and a Member-Supervisory Board at Strekin AG.
Dr. Inderbitzin obtained an MBA from the University of St. Gallen in 2002 and a doctorate from the University of Zurich in 1995.
Postes actifs de Silvio Inderbitzin
Sociétés | Poste | Début |
---|---|---|
KINARUS THERAPEUTICS HOLDING AG | Director/Board Member | - |
Vital Solutions Swiss AG | Chairman | 01/01/2015 |
Kinarus AG
Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The private company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | Director/Board Member | - |
Artidis AG
Artidis AG Medical SpecialtiesHealth Technology Artidis AG develops nano mechanical biomarkers for rapid cancer diagnostics. The private company is based in Basel, Switzerland. The Swiss company was founded by Marija Plodinec, Marko Loparic, Philipp Oertle, Tobias Appenzeller. Marija Plodinec has been the CEO since incorporation. | Director/Board Member | 01/05/2016 |
Helvecura Genossenschaft | Director/Board Member | - |
Hänseler AG
Hänseler AG Pharmaceuticals: MajorHealth Technology Hänseler AG manufactures and wholesales pharmaceutical products. It offers liquid, semi-solid and solid drug forms and drug substances in conformity with GMP. The firm manufactures galenical, which includes liquid, semi-solid and solid drug forms; and liquid extracts and tinctures. The company was founded by Edwin Hanseler in 1975 and is headquartered in Herisau, Switzerland. | Director/Board Member | 01/05/2016 |
Aurealis Pharma AG
Aurealis Pharma AG Miscellaneous Commercial ServicesCommercial Services Part of Aurealis Oy, Aurealis Pharma AG is a Swiss company that provides scientific research and development services. The private company is based in Basel, Switzerland. The company was founded by Juha Matti Yrjänheikki. | Director/Board Member | 01/04/2016 |
Krebsforschung Schweiz | Director/Board Member | - |
Swiss Cancer Foundation | Director/Board Member | - |
░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Silvio Inderbitzin
Sociétés | Poste | Fin |
---|---|---|
░░░░░░ ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Silvio Inderbitzin
University of St. Gallen | Masters Business Admin |
University of Zurich | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
SPEXIS AG | Health Technology |
KINARUS THERAPEUTICS HOLDING AG | Health Technology |
Entreprise privées | 20 |
---|---|
Spirig Pharma AG
Spirig Pharma AG Pharmaceuticals: MajorHealth Technology Spirig Pharma AG manufactures and distributes pharmaceutical products. The company was founded in 1948 and is headquartered in Egerkingen, Switzerland. | Health Technology |
Ulrich Jüstrich Holding AG
Ulrich Jüstrich Holding AG Investment ManagersFinance Ulrich Jüstrich Holding AG is an investment holding private company based in Walzenhausen, Switzerland. and has subsidiaries in Switzerland and France. The Swiss company operates as an investment holding company. | Finance |
Helvecura Cooperative Society | |
Hänseler AG
Hänseler AG Pharmaceuticals: MajorHealth Technology Hänseler AG manufactures and wholesales pharmaceutical products. It offers liquid, semi-solid and solid drug forms and drug substances in conformity with GMP. The firm manufactures galenical, which includes liquid, semi-solid and solid drug forms; and liquid extracts and tinctures. The company was founded by Edwin Hanseler in 1975 and is headquartered in Herisau, Switzerland. | Health Technology |
MEDUDEM AG
MEDUDEM AG Internet Software/ServicesTechnology Services MEDUDEM AG operates as a healthcare information services. It offers consulting and project management, digital solutions, pharmaceutical products, medical devices, diagnostics, and health management. The company was founded by Urs Wittwer in 2007 and is headquartered in Zurich, Switzerland. | Technology Services |
Krebsforschung Schweiz | |
Hänseler Holding AG | |
Nexilis AG
Nexilis AG BiotechnologyHealth Technology Nexilis AG is a Swiss medtech company that specializes in providing cost-effective fixation enhancement for any bone screw. The private company's flagship product is the Immediate Stabilisation System (ISS), which is an implantable polymer sleeve that is moulded around the pedicle screw using ultrasonic energy. Nexilis has a culture built around innovative science, precision, and quality, and has engaged in collaborations with renowned institutions to create safe and easy-to-implement solutions for surgeons. The company was founded by Martin Horst and the CEO is Leanna Caron. | Health Technology |
Swiss Cancer Foundation | |
Aurealis Oy
Aurealis Oy BiotechnologyHealth Technology Aurealis Oy operates as a biopharmaceutical company which develops treatment method that improves life for chronic inflammation and cancer sufferers. It develops a proprietary technology, which utilizes genetically modulated probiotics that deliver a variety of therapeutic proteins to diseased tissue, thus modulating local immune system and enabling healing. The company was founded by Dirk Weber and Thomas Wirth in 2010 and is headquartered in Kuopio, Finland. | Health Technology |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
Mavena International AG
Mavena International AG Pharmaceuticals: MajorHealth Technology Mavena International AG develops, manufactures, and markets medical care products for the treatment of chronic skin conditions. The company is headquartered in Huneberg, Switzerland. | Health Technology |
Strekin AG
Strekin AG BiotechnologyHealth Technology Strekin AG is a Swiss pharmaceutical company that develops pharmaceuticals, therapeutics, and vaccines. The private company was founded in 2014 and is based in Basel, Switzerland. | Health Technology |
Hthc High Tech Home Care AG | |
Just Finance AG | |
Vital Solutions Swiss AG | |
Aurealis Pharma AG
Aurealis Pharma AG Miscellaneous Commercial ServicesCommercial Services Part of Aurealis Oy, Aurealis Pharma AG is a Swiss company that provides scientific research and development services. The private company is based in Basel, Switzerland. The company was founded by Juha Matti Yrjänheikki. | Commercial Services |
Helvecura Genossenschaft | |
Artidis AG
Artidis AG Medical SpecialtiesHealth Technology Artidis AG develops nano mechanical biomarkers for rapid cancer diagnostics. The private company is based in Basel, Switzerland. The Swiss company was founded by Marija Plodinec, Marko Loparic, Philipp Oertle, Tobias Appenzeller. Marija Plodinec has been the CEO since incorporation. | Health Technology |
Kinarus AG
Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The private company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | Health Technology |